“You give ANYONE a 15% raise and a few shares in a growing concern and not only do you get the best..but, the best will recruit for you by dislodging those that are the best in their given field.”

If I’m reading this correctly, you’re saying we have a good chance at replacing NP and SK after COVID approval? We’ll likely have plenty of cash to pay a legitimate biotech CEO and to pay a Chief Medical Office who has relevant experience. Thank leronlimab, I’m excited.